UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers

Psychopharmacologia, 2007-05, Vol.191 (4), p.919-929

2007

Volltextzugriff (PDF)

Efficacy and safety of MIN-101: A new drug for the treatment of negative symptoms in schizophrenia a 12-week randomized, double blind, placebo-controlled trial

European psychiatry, 2017-04, Vol.41 (S1), p.S191-S191

Luthringer, R.

2017

Volltextzugriff (PDF)

The orexin-2 antagonist JNJ-42847922 (MIN-202) improves sleep in patients with major depressive disorder (MDD) suffering from comorbid insomnia

European neuropsychopharmacology, 2016-10, Vol.26, p.S408-S409

2016

Volltextzugriff (PDF)

S.09.04 New pharmacological treatments for negative symptoms: pitfalls and future perspectives of clinical trials

European neuropsychopharmacology, 2019-12, Vol.29, p.S6-S6

2019

Volltextzugriff (PDF)

Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man

Journal of psychopharmacology (Oxford), 2007-05, Vol.21 (3), p.321-337

2007

Volltextzugriff (PDF)

Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge

Journal of psychopharmacology (Oxford), 2010-05, Vol.24 (5), p.701-708

2010

Volltextzugriff (PDF)

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Journal of psychopharmacology (Oxford), 2019-02, Vol.33 (2), p.202-209

2019

Volltextzugriff (PDF)

Sleep stage scoring using the neural network model: comparison between visual and automatic analysis in normal subjects and patients

Sleep (New York, N.Y.), 1996-01, Vol.19 (1), p.26-35

1996

Volltextzugriff (PDF)

First-night effect in normal subjects and psychiatric inpatients

Sleep (New York, N.Y.), 1995-07, Vol.18 (6), p.463-469

1995

Volltextzugriff (PDF)

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia

International clinical psychopharmacology, 2009-09, Vol.24 (5), p.239-249

2009

Volltextzugriff (PDF)

Pharmacokinetics and Safety Profile of Ispronicline (TC-1734), a New Brain Nicotinic Receptor Partial Agonist, in Young Healthy Male Volunteers

Journal of clinical pharmacology, 2006-07, Vol.46 (7), p.715-736

2006

Volltextzugriff (PDF)

A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves

Sleep (New York, N.Y.), 1996-12, Vol.19 (10), p.817-824

1996

Volltextzugriff (PDF)

Sexual dimorphism in the brown algae

Perspectives in phycology, 2014-06, Vol.1 (1), p.11-25

2014

Volltextzugriff (PDF)

Efficacy and safety of MIN-101: a new drug in development for the treatment of negative symptoms in schizophrenia – a 12 weeks RCT

European neuropsychopharmacology, 2017-10, Vol.27, p.S928

2017

Volltextzugriff (PDF)

P.3.d.001 - Efficacy and safety of MIN-101: a new drug in development for the treatment of negative symptoms in schizophrenia – a 12 weeks RCT

European neuropsychopharmacology, 2017-10, Vol.27, p.S928-S928

2017

Volltextzugriff (PDF)

Sleep effects of a 24-h versus a 16-h nicotine patch: A polysomnographic study during smoking cessation

Sleep medicine, 2006-03, Vol.7 (2), p.147-154

2006

Volltextzugriff (PDF)

Psychotropic Profile of S 17092, a Prolyl Endopeptidase Inhibitor, Using Quantitative EEG in Young Healthy Volunteers

Neuropsychobiology, 2007-01, Vol.55 (3-4), p.176-183

2007

Volltextzugriff (PDF)

Alpha activity and cardiac correlates : three types of relationships during nocturnal sleep

Clinical neurophysiology, 2000-05, Vol.111 (5), p.940-946

2000

Volltextzugriff (PDF)

P.2.f.035 - JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

European neuropsychopharmacology, 2017-10, Vol.27, p.S866-S866

2017

Volltextzugriff (PDF)

JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

European neuropsychopharmacology, 2017-10, Vol.27, p.S866

2017

Volltextzugriff (PDF)

The place of electrophysiology in the proof of concept approach of psychotropic drug development

Methods and findings in experimental and clinical pharmacology, 2002, Vol.24, p.65-65

LUTHRINGER, R

2002

Volltextzugriff (PDF)

Pharmacodynamic Effects of Acamprosate on Markers of Cerebral Function in Alcohol-Dependent Subjects Administered as Pretreatment and during Alcohol Abstinence

Neuropsychobiology, 2004-01, Vol.50 (1), p.71-77

2004

Volltextzugriff (PDF)

P.1.b.013 Sleep assessments in patients with schizophrenia following treatment with paliperidone extended-release tablets

European neuropsychopharmacology, 2006, Vol.16, p.S224-S224

Luthringer, R.

2006

Volltextzugriff (PDF)

Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers

Addictive behaviors, 2006-03, Vol.31 (3), p.537-543

2006

Volltextzugriff (PDF)

The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

European neuropsychopharmacology, 2017-10, Vol.27, p.S655-S656

2017

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(127)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(149)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(83)
Humans
(77)
Male
(60)
Adult
(44)
Biological And Medical Sciences
(40)
Female
(32)
Middle Aged
(32)
Neurosciences & Neurology
(31)
Medical Sciences
(30)
Neurosciences
(26)
Psychiatry
(22)
Clinical Neurology
(19)
Double-Blind Method
(18)
Electroencephalography
(18)
Pharmacology & Pharmacy
(15)
Psychology. Psychoanalysis. Psychiatry
(15)
Sleep
(14)
Electroencephalography - Drug Effects
(13)
Surgery
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers

Efficacy and safety of MIN-101: A new drug for the treatment of negative symptoms in schizophrenia a 12-week randomized, double blind, placebo-controlled trial

The orexin-2 antagonist JNJ-42847922 (MIN-202) improves sleep in patients with major depressive disorder (MDD) suffering from comorbid insomnia

S.09.04 New pharmacological treatments for negative symptoms: pitfalls and future perspectives of clinical trials

Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man

Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Sleep stage scoring using the neural network model: comparison between visual and automatic analysis in normal subjects and patients

First-night effect in normal subjects and psychiatric inpatients

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia

Pharmacokinetics and Safety Profile of Ispronicline (TC-1734), a New Brain Nicotinic Receptor Partial Agonist, in Young Healthy Male Volunteers

A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves

Sexual dimorphism in the brown algae

Efficacy and safety of MIN-101: a new drug in development for the treatment of negative symptoms in schizophrenia – a 12 weeks RCT

P.3.d.001 - Efficacy and safety of MIN-101: a new drug in development for the treatment of negative symptoms in schizophrenia – a 12 weeks RCT

Sleep effects of a 24-h versus a 16-h nicotine patch: A polysomnographic study during smoking cessation

Psychotropic Profile of S 17092, a Prolyl Endopeptidase Inhibitor, Using Quantitative EEG in Young Healthy Volunteers

Alpha activity and cardiac correlates : three types of relationships during nocturnal sleep

P.2.f.035 - JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

The place of electrophysiology in the proof of concept approach of psychotropic drug development

Pharmacodynamic Effects of Acamprosate on Markers of Cerebral Function in Alcohol-Dependent Subjects Administered as Pretreatment and during Alcohol Abstinence

P.1.b.013 Sleep assessments in patients with schizophrenia following treatment with paliperidone extended-release tablets

Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers

The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

Suchergebnisse filtern